Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FNP6Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,821
Award facts
- Contract value 100% obligated
- $18,820.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injections, valued at $18,820.62 under a firm fixed-price contract. The award, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. Dupixent is a prescription biologic medication used to treat moderate-to-severe eczema, asthma, and other allergic conditions, making this a specialized pharmaceutical delivery supporting federal healthcare needs.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999.999 billion through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs and other federal health systems worldwide. As a major pharmaceutical distributor with extensive federal contracting experience, AmerisourceBergen Drug Corp maintains the capability to fulfill competitive procurement requirements across multiple therapeutic domains and geographic regions.
Quick answers
Who was awarded contract SPE2DR26FNP6Q?
SPE2DR26FNP6Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FNP6Q worth?
The government has obligated $18,821 on SPE2DR26FNP6Q.
Is contract SPE2DR26FNP6Q an order under another contract?
Yes. SPE2DR26FNP6Q is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNP6Q competed?
The extent of competition for SPE2DR26FNP6Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award